Gritstone bio
Overview
Gritstone Bio is a biotechnology company focused on developing personalized cancer immunotherapies and vaccines utilizing advanced genetic and molecular analysis. The company leverages genomic testing and tumor profiling to create targeted treatment solutions for cancer patients.
More in Genetic Testing
Latest industry news
Guardant Health's FDA-Cleared Genomic-Epigenomic Liquid Biopsy Panel Reshapes the Oncology Testing Landscape
2026-10-29 · Product
CSF DNA Testing Poised to Transform Brain Tumor Diagnosis
2026-10-28 · Research
Tempus AI Wins FDA Clearance for Pulmonary Hypertension Diagnostic Tool, Expanding Its Clinical AI Footprint
2026-10-27 · Product
Vietnam's Gene Solutions Eyes Hong Kong IPO to Fuel Regional Genomics Expansion
2026-10-26 · Industry
Company details
Category
🧬 Genetic Testing
Funding
Private
Listed
2026-07-29
Is this your company?
Claim this listing to add your logo, full description, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach genomics professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →